GlassScriptPhysician profile
Miles David Ashley
NPI 1518309277
$1,743.20
in general payments reported to CMS, 2019-2025
14 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.75 · 2020: $71.97 · 2021: $234 · 2022: $326 · 2023: $424 · 2024: $396 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $845.08 | 2021-2024 | Acthar |
| Johnson & Johnson Vision Care, INC. | $181.80 | 2019-2025 | Acuvue |
| Coopervision INC. | $142.28 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Glaukos Corporation | $138.28 | 2023-2025 | Photrexa Viscous and Photrexa, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Alcon Vision LLC | $118.42 | 2019-2025 | Total30, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.23 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $60.40 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $56.48 | 2020-2021 | |
| Allergan, INC. | $37.35 | 2021 | |
| Abbvie INC. | $23.68 | 2022 | |
| Dompe US, INC. | $22.92 | 2024 | Oxervate |
| Bausch & Lomb Americas INC. | $22.45 | 2025 | Infuse |
| Abb Con-Cise Optical Group LLC | $16.63 | 2025 | Contact Lens |
| Novartis Pharmaceuticals Corporation | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Ashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.